Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase13 Jun 2025Byline Bancorp IncBY:NYQWilliam G. KistnerIndependent Director16425.29
USD
4.15k USD
Purchase13 Jun 2025Byline Bancorp IncBY:NYQMary Jo S. HersethIndependent Director2,00025.33
USD
50.65k USD
Sale13 Jun 2025Direct Digital Holdings IncDRCT:NAQMark D. WalkerChairman of the Board and Chief Executive Officer6,9860.51
USD
3.56k USD
Purchase13 Jun 2025First Busey CorpBUSE:NSQSteven W. CapleIndependent Director3,30022.39
USD
73.89k USD
Sale13 Jun 2025FirstGroup PLCFGP:LSERyan Dirk MangoldExecutive Director,Chief Financial Officer50,0002.25
GBP
112.30k GBP
Sale13 Jun 2025FirstGroup PLCFGP:LSERyan Dirk MangoldExecutive Director,Chief Financial Officer950,0002.24
GBP
2.13m GBP
Purchase13 Jun 2025Rotork PLCROR:LSESvein Richard BrandtzaegNon-Executive Director5,5003.24
GBP
17.81k GBP
Purchase13 Jun 2025Hemogenyx Pharmaceuticals PLCHEMO:LSEVladislav SandlerExecutive Director,Chief Executive Officer250,0001.81
GBP
451.25k GBP
Purchase13 Jun 2025Fevertree Drinks PLCFEVR:LSEDavid LappNon-Executive Director24,59012.28
GBP
301.97k GBP
Purchase13 Jun 2025IRIDEX CorpIRIX:NAQPatrick MercerDirector, Chief Operating Officer, Chief Executive Officer and President2500.96
USD
240.00 USD
Purchase13 Jun 2025Ultralife CorpULBI:NMQBradford T. WhitmoreChairman of the Board10,0007.64
USD
76.39k USD
Purchase13 Jun 2025Ultralife CorpULBI:NMQJanie GoddardIndependent Director1,5487.68
USD
11.89k USD
Sale12 Jun 2025Build-A-Bear Workshop IncBBW:NYQCraig A. LeavittNon-Executive Chairman of the Board8,25050.21
USD
414.24k USD
Purchase12 Jun 2025Sellas Life Sciences Group IncSLS:NAQRobert L. Van NostrandIndependent Director10,0001.48
USD
14.80k USD
Purchase12 Jun 2025Eagle Financial Services IncEFSI:NAQEdward HillIndependent Director1,00029.93
USD
29.93k USD
23624 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.